Insurers Are Buying Longevity Medicine: What They Will Demand From Providers

Dr. Ana Baroni
Dr. Ana Baroni
Medical Strategy & Clinical Leadership

MD, PhD in Molecular Diagnostics (Cum Laude), with over 27 years of clinical practice in precision, regenerative, functional, and integrative medicine. She is Chief Scientific Officer at Longevity.Tech.fund and Chief Medical Officer at HealthyLongevity.clinic.

Insurers have started partnering with longevity providers. They may turn out to be longevity medicine’s most demanding clients.

What Insurers Announced in 2026

In July, Ping An unveiled 11 Health Longevity Centers across China. They are built on 11 existing Ping An health check-up centers, now run under one longevity brand.

In September, AIA Thailand announced a partnership with VitalLife Scientific Wellness Center, part of Bumrungrad International Hospital. From January 2027, more than 100,000 AIA Prestige Club members can use its personalized preventive and longevity services. Members who need more complex care can be referred to Bumrungrad’s specialists.

On October 8, AIA Alta, the high-net-worth arm of AIA Hong Kong and Macau, announced an exclusive collaboration in Hong Kong with Chi Longevity, a longevity medicine clinic based in Singapore. AIA Alta plans to open its own longevity center later this year.

The Commercial Case

In May, AIA published a longevity readiness index developed with BCG. It analyzed 201 respondents in Hong Kong and mainland China with more than US$1 million to invest. On a 100-point scale, longevity awareness scored 74 and preparedness scored 54. That gap is the commercial case.

What does this change for family offices, hospital groups, and hotel and resort groups? None of these announcements spells out what insurers will require from their partners. But the way insurers price risk points in three directions.

First: Insurers Will Count Years, Not Visits

Insurance renews every year. An offer that cannot show measured change at twelve months will struggle at renewal. Providers need a plan to track results over a full year, not only to sell a first visit.

Second: Insurers Trust Measures That Already Predict Risk

In July, Munich Re medical director Dr. Tim Meagher wrote in the Journal of Insurance Medicine that epigenetic clocks add minimal value to life insurance underwriting today. Age, medical history, and clinical biomarkers already do that job. He adds that newer multi-omic clocks may improve on this.

For now, established clinical and functional measures, tracked well, are easier for an insurer to trust than one biological age number.

Third: The Partner Becomes Part of the Policy

Once a provider sits inside an insurance offer, its failures become the insurer’s problem. The partner needs a clear route to specialist care, adverse event reporting, and data that survives an audit. A longer test menu is no substitute for these. AIA Thailand’s model already builds in referral to hospital specialists for complex cases.

Why Ping An's Model Matters

Ping An’s model is the one to watch most closely. Eleven centers under one insurer can do what no single clinic can. They can apply one clinical standard across sites, measure the same outcomes everywhere, and compare them year over year.

If Ping An builds that measurement in as the centers grow, they could become the reference dataset the field lacks.

What Providers Should Build Before an Insurer Calls

Providers can prepare now, in four steps. Define a small set of outcomes the program aims to change. Measure them at intake and again at twelve months. Record adverse events in one place. Document the route to specialist care.

With these in place, a provider can answer an audit without scrambling. The same records help physicians improve the program from one year to the next.

Why Measured Outcomes Help Providers Too

Insurers set a high bar, but the bar also protects serious providers. A clinic that tracks outcomes can show clients what changed. It can also set its offer apart from competitors that sell a longer test menu. Outcome tracking is a commercial advantage as well as a clinical discipline.

Build One Framework for Several Audiences

Providers that act early also gain credibility beyond insurers. Hospitals, employers, and family offices ask similar questions about results, so one outcome framework serves all of them. It also gives the medical director a factual way to decide which services to keep, which to change, and which to retire.

The Audit Question

This is good news for evidence-based longevity medicine, because it raises the bar for everyone. The question for every longevity program is simple. If an insurer audited your last 100 clients tomorrow, which three outcomes could you show?

Most teams can name the tests they ran. Very few can name the results they changed.

Key Takeaways

Insurers are now partnering with longevity providers, and they will likely audit what they buy. Expect them to count results over years, to trust measures that already predict risk, and to hold the partner accountable for clinical safety. Providers should track a small set of outcomes, record adverse events, and keep a clear route to specialist care. One clinical standard across sites makes results comparable. Providers that prepare now will find the audit easier.

Frequently Asked Questions

Which insurers entered longevity medicine in 2026?

In July, Ping An unveiled 11 Health Longevity Centers across China. In September, AIA Thailand partnered with VitalLife at Bumrungrad International Hospital. In October, AIA Alta, part of AIA Hong Kong and Macau, announced an exclusive collaboration in Hong Kong with Chi Longevity.

AIA’s index, developed with BCG and published in May 2026, analyzed 201 respondents in Hong Kong and mainland China with more than US$1 million to invest. On a 100-point scale, longevity awareness scored 74 and preparedness scored 54.

Munich Re medical director Dr. Tim Meagher wrote in July 2026 that epigenetic clocks add minimal value to life underwriting today. Age, medical history, and clinical biomarkers already do that job. Newer multi-omic clocks may change this, but tracked clinical and functional measures are easier to trust now.

Most likely a clear route to specialist care, adverse event reporting, and data that survives an audit. A longer test menu does not replace these.

If an insurer audited your last 100 clients tomorrow, which three outcomes could you show? Providers should be able to name results they changed, not only tests they ran.

Planning a longevity business?

TURN8 can review your readiness.

Scroll to Top